Home » Hereditary Testing Market

Hereditary Testing Market By Disease Type Outlook (Hereditary Cancer Testing, Hereditary Non-cancer Testing) By Technology Outlook (Cytogenetic, Biochemical, Molecular Testing) – Growth, Future Prospects & Competitive Analysis, 2016 – 2028

Price: $4999

Published: | Report ID: 6870 | Report Format : PDF

Market Insights

The global Hereditary Testing market report explores the critical analysis of the industry using key parameters. The report consists of investment strategies, the need for investments in the Hereditary Testing industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Hereditary Testing industry and how economic and non-economic barriers are helping the Hereditary Testing market grow. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

hereditary-testing-market

Key Highlights of the report

How are the major segments performing in the Hereditary Testing market?

In 2021, the hereditary cancer testing segment dominated the market due to the increased affordability of tests and the rising demand for DNA test kits.

In 2021, the molecular testing segment dominated and accounted for the largest share of the hereditary testing market. Genetic analysis is mostly utilized techniques of hereditary genetic counseling, which requires molecular testing equipment.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Which region dominated the Hereditary Testing market?

In 2021, North America region dominated the global Hereditary Testing market with the largest market share. The rapid growth of tubes due to awareness, the high incidence rate of cancer and favorable compensation policies have supported the growth of the hereditary testing market in North America. In addition, the growing government support and advanced healthcare sector also grow hereditary testing in the North American region. Furthermore, with the increasing number of manufacturing facilities, the product is available at the lowest cost. Technological advancements have also aided the growth of the North American region’s Hereditary Testing market.

What is the competitive environment of the Hereditary Testing market?

The hereditary testing industry’s competitive environment offers information on the total economic profit made by suppliers and businesses, the sales and revenues produced in this sector, the hereditary testing market share globally, the business organization overview, the introduction of new products, and the opportunities for the hereditary testing market. For instance, in January 2020, Blueprint Genetics was acquired for full cash by Quest Diagnostics, a provider of diagnostic information services. Blueprint Genetics interprets gene variants through next-generation sequencing (NGS) and proprietary algorithms. Quest and Blueprint Genetics will improve patient care and pharmaceutical medicine research and development by improving access to actionable insights into genetic and uncommon illnesses.

Executive Summary

What are all technical developments being developed in the Hereditary Testing Market?

Technical development for hereditary testing in cancer treatments. The global hereditary testing market’s expansion is driven by increased demand for cancer testing kits to boost productivity and efficiency. For instance, in June 2022, Myriad Genetics and Epic collaborated to provide genetic testing more accessible to patients through EHR integration. Similarly, in June 2022, Illumina launched a research test developed in collaboration with Merck to gain deeper insights into the tumor genome.

Which are the key investments by the players in the Hereditary Testing Market?

Hereditary testing solutions have been used in various industries due to their exceptional flexibility and capacity to be adaptable in any setting. Various investments are made among the key player. For instance, in August 2021, DnaNudge announced the successful completion of a USD 60 million Series A financing round headed by Ventura Capital. Similarly, in August 2021, Maven Capital, an active private equity firm, increased its investment in GENinCode, a genetic testing company specializing in risk assessment and predicting cardiovascular disease.

Some major market players are Myriad Genetics, Inc.; Invitae Corporation; Illumina, Inc.; Natera, Inc.; Laboratory Corporation of America Holdings; F. Hoffmann-La Roche Ltd; Quest Diagnostics Incorporated; CooperSurgical, Inc.; Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.

What are the Major Driving Factors for the Hereditary Testing market?

The major factor for the Hereditary Testing market is the rising prevalence of genetic disorders such as cancer and rising awareness of the benefits of genetic testing. The increasing need to find a cure for cancer creates demand for global genetic testing, which is expected to drive the hereditary testing market. The advancement in hereditary technology and rapid expansion in the biotechnology sector is expected to increase the growth. Additionally, there are many better product manufacturers and suppliers across the globe. Furthermore, the increasing adoption of inorganic growth of the market and decreasing cost sequences are also expected to increase the hereditary testing market growth.

What are the Major Risks for the Hereditary Testing market?

With the rising occurrence of cancer diseases, the equipment of hereditary panel testing created many issues, such as the criteria that patients have to meet to undergo tests and patient clinical management. The use of tests must be compliant with or recommended for genetic testing, which can be a limited number of tests. These factors are expected to hamper the hereditary tests market growth during the forecast period. Furthermore, the lack of trained technicians has also hampered the market growth.

Which is the key Disease type in the Market Hereditary Testing market

The disease type outlook is classified into hereditary cancer testing and hereditary non-cancer testing. Hereditary cancer testing dominated and accounted for the largest market share of the hereditary testing market. The increasing affordability of tests and the demand for DNA test kits supported the growth hereditary cancer testing segment growth. Furthermore, the non-cancer segment dominates the market during the forecast period as the product and service offers concerning various hereditary cancer testing expand continuously and are expected to grow in the hereditary testing market during the forecast period.

How is the Hereditary Testing market performing in regions?

In 2021, North America dominated with the highest market share in the global hereditary testing market. The rapid growth of tubes due to awareness, the high incident rate of cancer and favorable compensation policies are expected to grow the North American Hereditary Testing market. Furthermore, with the increasing number of manufacturing facilities, the product is available at the lowest cost, and technological advancement is expected to support the North American region’s Hereditary Testing market. In addition, the growing government support and advanced healthcare sector also grow hereditary testing in the North American region.

Europe is expected to grow considerably due to the increasing geriatric population. The high adoption of advanced treatments and recommendations provided by government agencies to ensure the hereditary testing service quality are expected to support the growth of the European Hereditary Testing market. Furthermore, the increasing manufacturers and awareness in European countries and the rising purchasing power of the middle-class population are increasing the market growth in this region. Therefore, such factors are attributed to the European region’s hereditary testing market growth.

What is the regulatory landscape for the Hereditary Testing market?

The regulatory landscape for this market is that governments are exploring a supportive regulatory approach across regions. In the past few years, many governments have heavily invested in healthcare infrastructure in many countries, while developing countries are also spending more on healthcare developments. Therefore, these types of supportive initiatives by the government are expected to encourage the market players to expand themselves and develop new products that support the global hereditary testing market during the forecast period.

What is the Market Size of the Hereditary Testing market regarding value?

The global hereditary testing market is anticipated to grow at a substantial CAGR of 6.10% in the upcoming years. The global hereditary testing market was estimated to be worth USD 5,729.5 Million in 2021 and was expected to be worth USD 8,173.51 Million by 2028.

What are the major players planning for the future of the Hereditary Testing market?

The key players in the hereditary testing market invest heavily in numerous cutting-edge technologies, including genetic testing. Furthermore, future scenarios suggest that well-known market players invest significantly in startups and medium-sized enterprises to deliver effective solutions to the industry. Large players are expected to buy or merge with major enterprises or startups to achieve a competitive advantage. For instance, in September 2022, Exact Sciences Corp. announced the acquisition of PreventionGenetics, a genetic testing laboratory, to add to its advanced cancer diagnostics portfolio and assist its entry into hereditary cancer testing (HCT). PreventionGenetics provides the clinical lab, experience, and fundamental technology required to expedite the availability of HCT and assist more people in understanding their germline risk of cancer and other diseases.

Segmentation of Global Hereditary Testing market-

Global Hereditary Testing Market – By Disease Type Outlook

  • Hereditary Cancer Testing
  • Hereditary Non-cancer Testing

Global Hereditary Testing market – By Technology Outlook

  • Cytogenetic
  • Biochemical
  • Molecular Testing

Global Hereditary Testing Market – By Region

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Hereditary Testing market
2.2. Global Hereditary Testing market, By Disease Type Outlook (Revenue, USD Million, 2018-2030)
2.3. Global Hereditary Testing market, By Technology Outlook (Revenue, USD Million, 2018-2030)
2.4. Global Hereditary Testing market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Hereditary Testing market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Disease Type Outlook (Revenue, USD Million, 2018-2030)
3.3.2. Technology Outlook (Revenue, USD Million, 2018-2030)
3.3.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Type
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted By Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Hereditary Testing market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Hereditary Testing market
7.1. Global Hereditary Testing market, By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Hereditary Testing market, By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2021 vs 2028 (in%)
7.1.3. Global Hereditary Testing market, By Hereditary Cancer Testing, 2016-2028 (US$ Bn)
7.1.4. Global Hereditary Testing market, By Hereditary Non-cancer Testing, 2016-2028 (US$ Bn)
7.2. Global Hereditary Testing market, By Technology Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Hereditary Testing market, By Technology Outlook (Revenue, USD Million, 2018-2030), 2021 vs 2028 (in%)
7.2.3. Global Hereditary Testing market, By Cytogenetic, 2016-2028 (US$ Bn)
7.3. Global Hereditary Testing market, By Biochemical, 2016-2028 (US$ Bn)
7.3.1. Global Hereditary Testing market, By Molecular Testing, 2016-2028 (US$ Bn)

8. North America Hereditary Testing market Analysis
8.1. North America Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Hereditary Testing market By Country, 2016-2028 (US$ Bn)
8.3.1. U.S.
8.3.1.1. U.S. Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
8.3.1.2. U.S. Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
8.3.1.3. U.S. Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
8.3.2. Canada
8.3.2.1. Canada Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
8.3.2.2. Canada Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
8.3.2.3. Canada Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)

9. Europe Hereditary Testing market Analysis
9.1. Europe Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Hereditary Testing market By Country, 2016-2028 (US$ Bn)
9.3.1. Germany
9.3.1.1. Germany Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.1.2. Germany Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
9.3.1.3. Germany Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
9.3.2. France
9.3.2.1. France Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.2.2. France Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
9.3.2.3. France Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
9.3.3. UK
9.3.3.1. UK Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.3.2. UK Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
9.3.4. UK Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
9.3.5. Italy
9.3.5.1. Italy Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.5.2. Italy Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
9.3.5.3. Italy Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
9.3.6. Spain
9.3.6.1. Spain Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.6.2. Spain Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
9.3.6.3. Spain Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
9.3.7. Rest of Europe
9.3.7.1. Rest of Europe Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
9.3.7.2. Rest of Europe Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
9.3.7.3. Rest of Europe Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)

10. Asia Pacific Hereditary Testing market Analysis
10.1. Asia Pacific Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Hereditary Testing market By Country, 2016-2028 (US$ Bn)
10.3.1. China
10.3.1.1. China Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.1.2. China Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
10.3.1.3. China Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
10.3.2. Japan
10.3.2.1. Japan Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.2.2. Japan Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
10.3.2.3. Japan Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
10.3.3. India
10.3.3.1. India Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.3.2. India Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
10.3.3.3. India Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
10.3.4. South Korea
10.3.4.1. South Korea Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.4.2. South Korea Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
10.3.4.3. South Korea Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
10.3.5. South-East Asia
10.3.5.1. South-East Asia Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.5.2. South-East Asia Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
10.3.5.3. South-East Asia Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
10.3.6. Rest of Asia Pacific
10.3.6.1. Rest of Asia Pacific Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
10.3.6.2. Rest of Asia Pacific Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
10.3.6.3. Rest of Asia Pacific Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)

11. Latin America Hereditary Testing market Analysis
11.1. Latin America Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Hereditary Testing market By Country, 2016-2028 (US$ Bn)
11.3.1. Brazil
11.3.1.1. Brazil Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
11.3.1.2. Brazil Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
11.3.1.3. Brazil Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
11.3.2. Mexico
11.3.2.1. Mexico Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
11.3.2.2. Mexico Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
11.3.2.3. Mexico Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
11.3.3. Rest of Latin America
11.3.3.1. Rest of Latin America Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
11.3.3.2. Rest of Latin America Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
11.3.3.3. Rest of Latin America Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)

12. Middle East and Africa Hereditary Testing market Analysis
12.1. Middle East and Africa Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030), 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Hereditary Testing market By Country, 2016-2028 (US$ Bn)
12.3.1. GCC Countries
12.3.1.1. GCC Countries il Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
12.3.1.2. GCC Countries Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
12.3.1.3. GCC Countries Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
12.3.2. South Africa
12.3.2.1. South Africa Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
12.3.2.2. South Africa Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
12.3.2.3. South Africa Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
12.3.3. Rest of Middle East and Africa
12.3.3.1. Rest of Middle East and Africa Hereditary Testing market Estimates and Forecast, 2016-2028 (US$ Bn)
12.3.3.2. Rest of Middle East and Africa Hereditary Testing By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
12.3.3.3. Rest of Middle East and Africa Hereditary Testing By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)

13. Company Profiles
13.1. Acadian Sea plants Ltd.
13.1.1. Company Overview
13.1.2. Products/Green Algae Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Myriad Genetics
13.3. Inc.
13.4. Invitae Corporation
13.5. Lllumina Inc.
13.6. Natera Inc.
13.7. Laboratory Corporation of America Holdings
13.8. F. Hoffmann-La Roche Ltd
13.9. Quest Diagnostics Incorporated
13.10. Cooper Surgical Inc.
13.11. Agilent Technologies Inc.
13.12. Thermo Fisher Scientific Inc.

List of Figures

FIG. 1 Global Hereditary Testing market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Hereditary Testing market Segmentation
FIG. 4 Global Hereditary Testing market, By Disease Type Outlook (Revenue, USD Million, 2018-2030) 2021 (US$ Bn)
FIG. 5 Global Hereditary Testing market, By Technology Outlook (Revenue, USD Million, 2018-2030)2021 (US$ Bn)
FIG. 6 Global Hereditary Testing market, By Geography, 2021 (US$ Bn)
FIG. 7 Attractive Investment Proposition, By Disease Type Outlook (Revenue, USD Million, 2018-2030) 2021
FIG. 8 Attractive Investment Proposition, By Technology Outlook (Revenue, USD Million, 2018-2030)2021
FIG. 9 Attractive Investment Proposition, By Geography, 2021
FIG. 10 Global Market Share Analysis of Key Hereditary Testing market Manufacturers, 2021
FIG. 11 Global Market Positioning of Key Hereditary Testing market Manufacturers, 2021
FIG. 12 Global Hereditary Testing market Value Contribution, By Disease Type Outlook (Revenue, USD Million, 2018-2030) 2021 & 2028 (Value %)
FIG. 13 Global Hereditary Testing market, By Hereditary Cancer Testing, Value, 2016-2028 (US$ Bn)
FIG. 14 Global Hereditary Testing market, By Hereditary Non-cancer Testing, Value, 2016-2028 (US$ Bn)
FIG. 15 Global Hereditary Testing market Value Contribution, By Technology Outlook (Revenue, USD Million, 2018-2030)2021 & 2028 (Value %)
FIG. 16 Global Hereditary Testing market, By Cytogenetic, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Hereditary Testing market, By Biochemical, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Hereditary Testing market, By Long Term Care Centers, Value, 2016-2028 (US$ Bn)
FIG. 19 U.S. Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 20 Canada Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 21 Germany Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 22 France Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 23 U.K. Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 24 Italy Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 25 Spain Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 26 Rest of Europe Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 27 China Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 28 Japan Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 29 India Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 30 South Korea Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 31 Southeast Asia Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 32 Rest of Asia Pacific Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 33 Latin America Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 34 Brazil Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 35 Mexico Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 36 Rest of Latin America Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 37 Middle East & Africa Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 38 GCC Countries Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 39 South Africa Hereditary Testing market 2016-2028 (US$ Bn)
FIG. 40 Rest of Middle East and Africa Hereditary Testing market 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Hereditary Testing market
TABLE 2 Global Hereditary Testing market, By Competitive Benchmarking, 2021
TABLE 3 Global Hereditary Testing market, By Geographical Presence Analysis, 2021
TABLE 4 Global Hereditary Testing market, By Key Strategies Analysis, 2021
TABLE 5 Global Hereditary Testing market, By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 6 Global Hereditary Testing market, By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 7 Global Hereditary Testing market, By Geography, 2016-2028 (US$ Bn)
TABLE 8 North America Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 9 North America Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 10 North America Hereditary Testing market By Country, 2016-2028 (US$ Bn)
TABLE 11 US Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 12 US Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 13 Canada Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 14 Canada Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 15 Europe Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 16 Europe Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 17 Europe Hereditary Testing market By Country, 2016-2028 (US$ Bn)
TABLE 18 Germany Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 19 Germany Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 20 France Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 21 France Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 22 UK Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 23 UK Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 24 Italy Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 25 Italy Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 26 Spain Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 27 Spain Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 28 Rest of Europe Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 29 Rest of Europe Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 30 Asia Pacific Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 31 Asia Pacific Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 32 Asia Pacific Hereditary Testing market By Country, 2016-2028 (US$ Bn)
TABLE 33 China Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 34 China Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 35 Japan Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 36 Japan Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 37 India Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 38 India Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 39 South Korea Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 40 South Korea Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 41 South East Asia Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 42 South East Asia Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 43 Rest of Asia Pacific Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 44 Rest of Asia Pacific Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 45 Latin America Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 46 Latin America Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 47 Latin America Hereditary Testing market By Country, 2016-2028 (US$ Bn)
TABLE 48 Brazil Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 49 Brazil Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 50 Mexico Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 51 Mexico Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 52 Rest of Latin America Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 53 Rest of Latin America Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 54 Middle East and Africa Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 55 Middle East and Africa Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 56 Middle East and Africa Hereditary Testing market By Country, 2016-2028 (US$ Bn)
TABLE 57 GCC Countries Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 58 GCC Countries Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 59 South Africa Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 60 South Africa Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)
TABLE 61 Rest of Middle East and Africa Hereditary Testing market By Disease Type Outlook (Revenue, USD Million, 2018-2030), 2016-2028 (US$ Bn)
TABLE 62 Rest of Middle East and Africa Hereditary Testing market By Technology Outlook (Revenue, USD Million, 2018-2030)2016-2028 (US$ Bn)

Frequently Asked Questions

Which key factors will influence the hereditary testing market growth over 2022-2028?

The major factor for the Hereditary Testing market is the rising prevalence of genetic disorders such as cancer and rising awareness of the benefits of genetic testing. The increasing need to find a cure for cancer creates demand for global genetic testing, which is expected to drive the hereditary testing market. The advancement in hereditary technology and rapid expansion in the biotechnology sector is expected to increase the growth. Additionally, there are many better product manufacturers a

What will be the value of the hereditary testing market during 2022-2028?

The global hereditary testing market is anticipated to grow at a substantial CAGR of 6.10% in the upcoming years. The global hereditary testing market was estimated to be worth USD 5,729.5 Million in 2021 and was expected to be worth USD 8,173.51 Million by 2028.

Which region will contribute notably towards the hereditary testing market value?

In 2021, North America dominated with the highest market share in the global hereditary testing market. The rapid growth of tubes due to awareness, the high incident rate of cancer and favorable compensation policies are expected to grow the North American Hereditary Testing market. Furthermore, with the increasing number of manufacturing facilities, the product is available at the lowest cost, and technological advancement is expected to support the North American region’s Hereditary Testing ma

Which are the significant players leveraging the hereditary testing market growth?

The main competitors dominating the global hereditary testing market include Myriad Genetics Inc., Invitae Corporation, Illumina Inc., Natera Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical Inc., Agilent Technologies Inc., and Thermo Fisher Scientific Inc.

Which is the major segment in the hereditary testing market by closure type?

In 2021, the molecular testing segment dominated and accounted for the largest share of the hereditary testing market. Genetic analysis is mostly utilized techniques of hereditary genetic counseling, which requires molecular testing equipment.

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Venous Thromboembolism (VTE) Treatment Market

Published:
Report ID: 11666

X-Ray Equipment Market

Published:
Report ID: 9306

In-Vitro Diagnostics (IVD) Market

Published:
Report ID: 6408

Standalone Intraoral Scanners Market

Published:
Report ID: 9690

Healthcare Analytical Testing Market

Published:
Report ID: 7179

Iron Deficiency Injectable Market

Published:
Report ID: 32525

Fixed and Mobile C Arms Market

Published:
Report ID: 32518

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN